United Therapeutics Corporation logo

United Therapeutics Corporation (UTHR)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
549. 47
+9.42
+1.74%
$
24.23B Market Cap
11.96 P/E Ratio
- Div Yield
314,188 Volume
24.04 Eps
$ 540.05
Previous Close
Add Transaction
Day Range
541.1 551.89
Year Range
272.12 609.35
Want to track UTHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 months ago
United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

United Therapeutics Corporation (UTHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 4 months ago
UTHR or MDGL: Which Is the Better Value Stock Right Now?

UTHR or MDGL: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Drugs sector have probably already heard of United Therapeutics (UTHR) and Madrigal (MDGL). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 4 months ago
UTHR vs. ZTS: Which Stock Is the Better Value Option?

UTHR vs. ZTS: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Drugs sector might want to consider either United Therapeutics (UTHR) or Zoetis (ZTS). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 4 months ago
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 5 months ago
Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 5 months ago
Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock

Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 5 months ago
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 5 months ago
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 5 months ago
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 6 months ago
United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 Transcript

United Therapeutics Corporation ( UTHR ) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Company Participants Harrison Silvers - Manager of Investor Relations James Edgemond - CFO & Treasurer Conference Call Participants Jiale Song - Jefferies LLC, Research Division Presentation Jiale Song Jefferies LLC, Research Division Welcome, everyone, to Jefferies London Healthcare Conference 2025. My name is Roger Song, one of the senior analysts cover SMid-cap biotech in the U.S. It is my pleasure to have the fireside chat with our next company, United Therapeutics, James and Harry.

Seekingalpha | 6 months ago
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term

Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 6 months ago
Loading...
Load More